title: New dermatological agents for the treatment of psoriasis.
authors.affiliation: Department of Biology, Allergan Inc., Irvine, California 92623, USA.
authors.forename: S M
authors.initials: SM
authors.lastname: Thacher
authors.forename: J
authors.initials: J
authors.lastname: Vasudevan
authors.forename: K Y
authors.initials: KY
authors.lastname: Tsang
authors.forename: S
authors.initials: S
authors.lastname: Nagpal
authors.forename: R A
authors.initials: RA
authors.lastname: Chandraratna
mesh_terms: D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000378:metabolism / Q000627:therapeutic use; D002762:Cholecalciferol / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005938:Glucocorticoids; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008024:Ligands; D008727:Methotrexate / Q000627:therapeutic use; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology; D018160:Receptors, Cytoplasmic and Nuclear / Q000187:drug effects; D011987:Receptors, Steroid / Q000187:drug effects; D014801:Vitamin A / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D008024:Ligands; D018160:Receptors, Cytoplasmic and Nuclear; D011987:Receptors, Steroid; D014801:Vitamin A; D002762:Cholecalciferol; D008727:Methotrexate